Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment remdesivir.
Tuesday, May 12, 2020
Tags
# NEWS
# World
About KTA
KnownToAll is a news site, where you can get all latest news updates. All kind of news like World news, Indian news, Sports news, Technology news every thing is available here. So, what are you thinking? Just subscribe to our newsletter to get all news update before anyone.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment